The Difference Between Cystatin C– and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)
Onur Potok, Joachim H. Ix, Michael G. Shlipak, Ronit Katz, Amret Hawfield, Michael V. Rocco, Walter T. Ambrosius, Monique E. Cho, Nicholas M. Pajewski, Anjay Rastogi, Dena E. Rifkin
Topics & Concepts
MedicineSprintBlood pressureCystatin CCreatinineCohortInternal medicineRenal functionAdverse effectCohort studyPhysical therapyChronic Kidney Disease and DiabetesFrailty in Older AdultsDialysis and Renal Disease Management